DIA is hosting a series of content previews around the United States counting down to the DIA 2024 Global Annual Meeting, download the recording today!

Get a special glimpse of DIA 2024’s exciting content offerings during a panel discussion on the transformative impact of regenerative AI on pharmacovigilance (PV). Gain insights on how the pharmacovigilance landscape will change, and what drug safety professionals must do to stay relevant in a world of generative AI. This panel discussion promises an insightful journey into the future of PV, equipping professionals with the knowledge and strategies needed to thrive in a world where generative AI revolutionizes drug safety practices. Join us for this pivotal discussion as we navigate the changing PV landscapes together. #PVRevolution #AIInPharma #DIA2024


Hear from our esteemed panel

• Axel Hagel, Practice Leader, PV & RM Services IQVIA

• Mariette Boerstoel-Streefland, MD, MS, MBA, Senior Vice President, Worldwide Patient Safety Officer, Global Drug Development, Bristol-Myers Squibb Company

• Tracey P. Boone, MBA, MT(ASCP), Director, Technology & Innovation,Pharmacovigilance, Patient Safety, Epidemiology & RDQA (PSEQ), AbbVie

• Annette S. Williams, MBA, RPh, Vice President, Pharmacovigilance, IQVIA

Thank you to our sponsor:

The DIA 2024 Global Annual Meeting is coming to San Diego in June! San Diego is a unique intersection of one of the top life science markets in the world with a bustling tech start-up and innovation hub. Home to major research institutes, universities, and small biotechnology and tech companies, this area has sustained steady growth over the past decade. DIA members and their colleagues are leaders and contribute to San Diego’s healthcare product development successes. We are so excited to continue our year-long series of events building up to the DIA 2024 Global Annual Meeting. This annual gathering will bring thousands of biopharma researchers, developers, and regulators from around the world to San Diego!